M-m-r II vaccine vials
Ended Awarded
- Contract number
- SPE2DB26FP6WN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,934
Award facts
- Contract value 100% obligated
- $40,934.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,934.25 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for M-M-R II vaccine vials. The award, issued on October 23, 2025, with an ultimate completion date of October 24, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, leveraging its small business status and established performance record to support Department of Defense medical supply requirements.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded in November 2025 with a $499.999 billion ceiling value and completion date of December 31, 2036. The underlying IDC represents a 30-month base period with three 30-month option periods and positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors within the broader $30.3 billion PPV-G GEN V acquisition strategy. The contract authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to support recurring medical supply needs of military healthcare facilities worldwide, with DMS Pharmaceutical Group demonstrating established capability to fulfill diverse and specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FP6WN?
SPE2DB26FP6WN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FP6WN worth?
The government has obligated $40,934 on SPE2DB26FP6WN.
Is contract SPE2DB26FP6WN an order under another contract?
Yes. SPE2DB26FP6WN is a delivery order under SPE2DB22D9311, an indefinite delivery contract.
Was contract SPE2DB26FP6WN competed?
The extent of competition for SPE2DB26FP6WN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award